Guangzhou Innogen Pharmaceutical Group Co., Ltd (HKG:2591)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
20.90
+0.60 (2.96%)
At close: Mar 27, 2026

HKG:2591 Statistics

Total Valuation

HKG:2591 has a market cap or net worth of HKD 9.55 billion. The enterprise value is 8.39 billion.

Market Cap9.55B
Enterprise Value 8.39B

Important Dates

The last earnings date was Monday, March 23, 2026.

Earnings Date Mar 23, 2026
Ex-Dividend Date n/a

Share Statistics

HKG:2591 has 456.82 million shares outstanding. The number of shares has increased by 3.44% in one year.

Current Share Class 420.29M
Shares Outstanding 456.82M
Shares Change (YoY) +3.44%
Shares Change (QoQ) n/a
Owned by Insiders (%) 10.12%
Owned by Institutions (%) 46.74%
Float 246.28M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 65.24
PB Ratio 8.14
P/TBV Ratio 8.32
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -22.09
EV / Sales 57.35
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.93, with a Debt / Equity ratio of 0.16.

Current Ratio 2.93
Quick Ratio 2.67
Debt / Equity 0.16
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -201.99

Financial Efficiency

Return on equity (ROE) is -36.91% and return on invested capital (ROIC) is -21.40%.

Return on Equity (ROE) -36.91%
Return on Assets (ROA) -17.30%
Return on Invested Capital (ROIC) -21.40%
Return on Capital Employed (ROCE) -32.52%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee 1.39M
Profits Per Employee -3.62M
Employee Count 105
Asset Turnover 0.10
Inventory Turnover 0.20

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average 26.42
200-Day Moving Average n/a
Relative Strength Index (RSI) 37.10
Average Volume (20 Days) 864,040

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, HKG:2591 had revenue of HKD 146.34 million and -379.87 million in losses. Loss per share was -0.88.

Revenue146.34M
Gross Profit 130.26M
Operating Income -385.95M
Pretax Income -379.87M
Net Income -379.87M
EBITDA -369.80M
EBIT -385.95M
Loss Per Share -0.88
Full Income Statement

Balance Sheet

The company has 1.34 billion in cash and 185.01 million in debt, with a net cash position of 1.16 billion or 2.53 per share.

Cash & Cash Equivalents 1.34B
Total Debt 185.01M
Net Cash 1.16B
Net Cash Per Share 2.53
Equity (Book Value) 1.17B
Book Value Per Share 2.62
Working Capital 1.08B
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Depreciation & Amortization 16.44M
Net Borrowing n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 89.01%, with operating and profit margins of -263.72% and -259.57%.

Gross Margin 89.01%
Operating Margin -263.72%
Pretax Margin -259.57%
Profit Margin -259.57%
EBITDA Margin -252.69%
EBIT Margin -263.72%
FCF Margin n/a

Dividends & Yields

HKG:2591 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -3.44%
Shareholder Yield -3.44%
Earnings Yield -3.98%
FCF Yield n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score n/a